Memokath® 044TW Stent for Treatment of Urethral Stricture (NCT00270504) | Clinical Trial Compass
CompletedPhase 3
Memokath® 044TW Stent for Treatment of Urethral Stricture
United States92 participantsStarted 2002-12
Plain-language summary
The purpose of this study is to evaluate if the placement of a temporary urethral stent for up to 12 months, following dilation or internal urethrotomy (cutting open), results in a higher rate of urethral patency during the first year of follow-up when compared to the control group that does not receive a stent.
Who can participate
Age range
21 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Males \> 21 years of age
. Recurrent stricture of the bulbar urethra:
. \< 50 mm in length on urethrography; and which
. has a segment unable to accommodate a 16Fr flexible cystoscope
. Healthy tissue on both sides of stent
. Urinary flow in the abnormal range of the Siroky nomogram.
. Written informed consent obtained prior to participation in the study
. Patients must be available for all follow-up visits.
Exclusion criteria
. Strictures:
. outside the bulbous urethra
. associated with, or suspected to be, urethral carcinoma
. secondary to pelvic distraction injuries
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.